Oculis Holding AG Warrant (OCSAW)
Market Closed
3 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 50
+0.67
+17.4935%
$
- Market Cap
- P/E Ratio
- Div Yield
277 Volume
- Eps
$ 3.83
Previous Close Want to track OCSAW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
OCSAW closed Monday higher at $4.5, an increase of 17.4935% from Friday's close, completing a monthly decrease of -54.5835% or -$5.41. Over the past 12 months, OCSAW stock lost -54.5835%.
OCSAW is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
OCSAW Chart
Oculis Holding AG Warrant (OCSAW) FAQ
What is the stock price today?
The current price is $4.50.
On which exchange is it traded?
Oculis Holding AG Warrant is listed on NASDAQ (NMS).
What is its stock symbol?
The ticker symbol is OCSAW.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Oculis Holding AG Warrant ever had a stock split?
No, there has never been a stock split.
Oculis Holding AG Warrant Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | - CEO | NASDAQ (NMS) Exchange | CH1246223429 ISIN |
| US Country | 32 Employees | - Last Dividend | - Last Split | - IPO Date |
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
Contact Information
Address: -
Phone: -
